QuantHealth
QuantHealth Ltd. is an Israel-based AI company providing an enterprise clinical trial simulation platform powered by its proprietary LRDM v1.0 pharmaco-clinical foundation model and 350M-life real-world database, serving top-50 global pharmaceutical and biotechnology sponsors.
- Company typePrivate
- Founded2020
- HeadquartersTel Aviv, Israel
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What QuantHealth does
QuantHealth Ltd. is an Israel-based AI clinical trial simulation company founded in 2020 by Orr Inbar (CEO) and Arnon Horev (CSO/Operations), headquartered in Tel Aviv at the Azrieli Triangle Tower with a US commercial office in Worcester, Massachusetts. The company operates an enterprise platform that simulates clinical trial outcomes at single-patient resolution rather than cohort averages, by combining a proprietary biomedical knowledge graph (5M+ datapoints from 30+ curated sources mapping the biological cascade from therapeutic entity to target, pathway, cell, anatomy, and disease) with a real-world multimodal dataset spanning 350 million lives and over 10,000 data points per patient. On top of this data layer sits the Large Real-World Drug Model (LRDM v1.0), described as the industry's first pharmaco-clinical foundation model for life sciences, capable of processing 100M+ patients and billions of therapeutic datapoints in a single simulation. The platform is organized into Clinical Development (protocol optimization, indication selection, TPP, probability of technical success, market forecasting, enrollment prediction), Business Development (search & evaluation, asset diligence & valuation), and Portfolio Management (asset prioritization, gaps and opportunities) modules, with a newer Predictive Competitive Positioning capability bridging clinical and commercial strategy. Prospectively validated endpoint prediction accuracy is reported at 85% on primary endpoints (IMVOKE010, TROPION-Breast, ELOQUENT-1), with up to 90% prediction accuracy across the 600+ simulated clinical trials in nearly 30 therapeutic areas.
QuantHealth sells primarily to top-50 global pharmaceutical and biotechnology sponsors under quote-based, multi-year enterprise contracts accessed through "Book a Demo" CTAs; pricing is not publicly disclosed. Revenue mechanics combine platform subscriptions with strategic co-development engagements functioning as a land-and-expand motion. The company has reported 8x sales growth in 2025 and has cited customer outcomes including $31.4M in savings delivered to a top-10 pharma, $256M from salvaging a phase 3 head-and-neck cancer trial, and $141M from accelerated MASH trial timelines. The company is privately held under QuantHealth Ltd. (Israeli jurisdiction) and has raised approximately $17M+ to date: a $15M Series A in August 2023 led by Bertelsmann Investments and Pitango VC, a ~$2M strategic investment from Accenture Ventures via Project Spotlight in January 2024, and an undisclosed strategic investment from Sanofi Ventures in October 2025. Certifications include ISO 27001, SOC 2 Type 2, SOC 3, and GDPR/UK GDPR compliance with Standard Contractual Clauses for international transfers.
QuantHealth firmographics
Firmographics- Name
- QuantHealth
- Legal name
- QuantHealth Ltd.
- Website
- https://quanthealth.ai
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- QuantHealth Ltd. is an Israel-based AI company providing an enterprise clinical trial simulation platform powered by its proprietary LRDM v1.0 pharmaco-clinical foundation model and 350M-life real-world database, serving top-50 global pharmaceutical and biotechnology sponsors.
- Ownership category
- akta.pro rank
Where QuantHealth is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
QuantHealth business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Enterprise clinical trial simulation platform subscriptions: Primary revenue stream from licensed access to the QuantHealth clinical trial simulation platform sold to pharmaceutical and biotechnology sponsors under enterprise agreements. Sales growth was 8x in 2025 and the platform has been deployed across 600+ simulated trials and ~30 therapeutic areas. Pricing is not publicly disclosed; engagement model is quote-based and accessed via 'Book a Demo' CTAs.
- Strategic / co-development engagements with life sciences organizations: Revenue driven by new and expanding engagements with life sciences organizations, including deep protocol-design and portfolio-prioritization engagements (e.g., the top-10 pharma deployment that delivered $31.4M in savings). Functions as a land-and-expand motion on top of platform subscriptions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise engagement — quote-based, not publicly disclosed |
Go-to-market motion1 record
Marketing channels6 records
QuantHealth product offering
Product offeringCore offering
QuantHealth sells an AI-powered clinical trial simulation platform that simulates how individual patients will respond to any investigational or approved therapy at patient-level resolution. Built on a 350M-life real-world database, a proprietary biomedical knowledge graph, and the LRDM v1.0 foundation model, the platform supports protocol design and optimization, indication selection, probability of technical success, enrollment and market forecasting, business development asset diligence, and portfolio prioritization for pharmaceutical and biotechnology sponsors.
Product overview
QuantHealth offers a single unified AI-powered clinical trial simulation platform, augmented by a proprietary pharmaco-clinical foundation model (Large Real-World Drug Model / LRDM v1.0). The platform is organized into three primary solution areas — Clinical Development (protocol design & optimization, indication selection, TPP, PTS, market forecasting, enrollment prediction), Business Development (search & evaluation, comparative deep dive, asset diligence & valuation, out-licensing & disposition), and Portfolio Management (asset prioritization, asset synergy & overlap, gaps & opportunities) — with a newer Predictive Competitive Positioning capability bridging clinical and commercial strategy. The underlying LRDM foundation model, together with an integrated biomedical, clinical, and epidemiological data framework covering 350M lives and 100K+ drug entities, powers patient-level simulation of treatment response at 85–90% accuracy across nearly 30 therapeutic areas.
Differentiator
Problem solved
Functional benefit
Products and services
- QuantHealth Platform
Quantifiable outcome
- 8x sales growth in 2025 across life sciences organizations
- +6 more outcomes
Companies that use QuantHealth
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
QuantHealth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability9 records
Feature7 records
QuantHealth partnerships and signals
Strategic signalScale indicators11 records
Recent moves5 records
Expansion highlights6 records
QuantHealth competitors and assessment
Company assessmentDirect peers
- Unlearn.AI: AI-driven clinical trial simulation platform focused on generating prognostic control arms and forecasting patient outcomes; directly comparable to QuantHealth's patient-level digital-twin approach for protocol design.
- Owkin: AI for clinical research and drug development, applying machine learning to real-world patient data to optimize trial design and predict treatment response; comparable AI-for-clinical-trials positioning.
- ConcertAI: Real-world evidence and AI-driven clinical trial solutions for pharma and biotech; competes in the same enterprise pharma AI/clinical-development category.
Broad incumbents
- Tempus AI: Large real-world data and AI platform serving oncology and broader clinical development across pharma; overlaps with QuantHealth's real-world data-driven simulation but at much broader scale.
- Medidata Solutions (Dassault Systèmes): Enterprise clinical trial technology platform used by most large pharma sponsors; a broad incumbent competing for protocol design and simulation budget alongside QuantHealth.
- IQVIA: Largest CRO and clinical development technology vendor with deep data assets; competes for the same clinical trial simulation and protocol optimization wallet.
Emerging players
- Exscientia: AI-driven drug discovery and clinical development company; shares the AI-for-pharma-clinical-decisions positioning but is more drug-discovery-focused than trial-simulation-focused.
- Recursion: AI-driven drug discovery platform combining high-throughput biology with ML; comparable AI-for-life-sciences positioning with broader drug-discovery scope.
- Insilico Medicine: AI foundation-model-driven drug discovery and clinical development; adjacent through shared pharma AI and foundation model narratives.
- Cyclica: AI-augmented drug discovery platform serving pharma R&D; comparable AI-for-pharma enterprise SaaS model, though focused upstream on discovery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
QuantHealth social profiles
Digital presenceQuantHealth compliance and trust
Trust signalCompliance4 records
QuantHealth financial estimates
Financial estimateRevenue estimate
Valuation estimate
QuantHealth leadership team
Management profileNumber of profiles
Profiles15 records
QuantHealth funding detail
Funding detailFunding overview
Funding rounds5 records
Investors15 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QuantHealth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QuantHealth
What does QuantHealth do?
QuantHealth sells an AI-powered clinical trial simulation platform that simulates how individual patients will respond to any investigational or approved therapy at patient-level resolution. Built on a 350M-life real-world database, a proprietary biomedical knowledge graph, and the LRDM v1.0 foundation model, the platform supports protocol design and optimization, indication selection, probability of technical success, enrollment and market forecasting, business development asset diligence, and portfolio prioritization for pharmaceutical and biotechnology sponsors.
Is QuantHealth a public or private company?
QuantHealth is a private company. It is classified as venture growth investor backed and is currently operating.
When was QuantHealth founded?
QuantHealth was founded in 2020. It employs 101 to 250 people.
Where is QuantHealth based?
QuantHealth is headquartered in Tel Aviv, Israel, in the Middle East region.
How does QuantHealth make money?
Two revenue lines are on record. Enterprise clinical trial simulation platform subscriptions are the primary driver. The others are strategic / co-development engagements with life sciences organizations.
Who are QuantHealth's main competitors?
Direct peers on record are Unlearn.AI, Owkin and ConcertAI. Broad incumbents are Tempus AI, Medidata Solutions (Dassault Systèmes) and IQVIA. Emerging players are Exscientia, Recursion, Insilico Medicine and Cyclica.
Does QuantHealth have an API?
No public API is recorded for QuantHealth.